Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

What Did Big Pharma Earnings Say About China Growth?

This article was originally published in PharmAsia News

Executive Summary

Moving from a mixed to a more pessimistic outlook, top executives at multinational drug firms see China as fast losing its shine, despite the country continuing to lead growth in the emerging markets. PharmAsia News has combed through quarterly earnings reports to bring you the winners, laggards and most successful growth strategies in this increasingly challenging market.

Advertisement

Related Content

China Pediatric Slowdown Prompts Abbott Caution
Bounce Or More Bumps? New China Market Data Offer Bit Of Both

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register